Short Bowel Syndrome
Short Bowel Syndrome is a rare disorder characterized by inadequate nutrient absorption due to a significant portion of the small intestine being missing or removed, primarily causing symptoms such as diarrhea, which can lead to complications like dehydration, malnutrition, and weight loss. Additional symptoms may include bloating, heartburn, fatigue, and foul-smelling stool, with potential complications including anemia and kidney stones.
Health Outcomes
- Advanced Necrotizing Enterocolitis
- Altered Intestinal Transit
- Changed Phosphate Level
- Comparable D-Lactate Production
- Decreased Stool pH
- Enhanced GLP-2 Secretion
- Enhanced Growth Performance
- Enhanced Growth Rate
- Enhanced Growth and Development
- Enhanced Ileal Development
- Enhanced Intestinal Development
- Enhanced Nutrient Utilization
- Enhanced Prebiotic Activity
- Enhanced Small Intestine Metabolic Function
- Improved Amino Acid Absorption
- Improved Digestibility of Amino Acids
- Improved Enteral Nutrition
- Improved Enteral Nutrition Tolerance
- Improved Enteral Nutrition Uptake
- Improved Faecal Dry Matter
- Improved Fecal Acetate Recovery
- Improved Gastrointestinal Microbiome Balance
- Improved Growth
- Improved Growth Metrics
- Improved Gut Barrier Morphology
- Improved Gut Microbiota Colonization
- Improved Gut Repair
- Improved Ileal Histomorphometry
- Improved Intestinal Barrier
- Improved Intestinal Injury
- Improved Intestinal Transit
- Improved Intestinal Villus Height
- Improved Jejunal Morphology
- Improved Malnutrition Status
- Improved Micronutrient Availability
- Improved Mineral Absorption
- Improved Nutrient Absorption
- Improved Nutrient Absorption and Metabolism
- Improved Palatability and Textural Quality
- Improved Protein Absorption
- Improved Protein Hydrolysis Capacity
- Improved Recovery from Malnutrition
- Improved Serum Protein Status
- Improved Small Intestinal Tissue Maturation
- Improved Small Intestine Length
- Improved Starch Degradation Potential
- Improved Strain-Level Competitive Fitness
- Improved Villus Height
- Improved Villus Height in Duodenum
- Improved Zinc Absorption
- Increased Epithelial Proliferation in the Small Intestine
- Increased Fecal Energy Excretion
- Increased Fecal Moisture Content
- Increased Fecal Output
- Increased Folate Production
- Increased Functional Gene Abundance in Small Intestine
- Increased GLP-2 Level
- Increased GLP-2 Release
- Increased Gut Hormone Level
- Increased Ileum Length
- Increased Intestinal Motility
- Increased Magnesium Absorption
- Increased Oxalate-Degrading Activity
- Increased Peptide YY Level
- Increased Prebiotic Fermentation Activity
- Increased Protein Digestibility
- Increased Urinary Abundance of Nutrient-Related Metabolites
- Increased Valeric Acid Levels
- Increased Villus Height to Crypt Depth Ratio
- Lack of Protection of Intestinal Morphology Against DON
- Maintained Nutritional Quality
- Necrotizing Enterocolitis Stage II or Higher
- No Change in Nutrient Digestibility or Blood/Immune Markers
- No Improvement in Growth Performance
- No Increase in Fecal Incontinence
- No Significant Change in Gut Transit Time
- Normal Growth Performance
- Normalized Gut Metabolites
- Prevented Exacerbation of Thiamine Deficiency
- Rapid Galactooligosaccharide Degradation During Gastrointestinal Transit
- Recovered Colon Length
- Reduced Anthropometric Parameters
- Reduced Bile Acid Reabsorption
- Reduced Coliform Levels in the Jejunum
- Reduced Constipation Incidence
- Reduced Copper Level
- Reduced D-Lactic Acidosis
- Reduced Diarrhea Severity
- Reduced Duration of Parenteral Nutrition
- Reduced Feeding Intolerance
- Reduced Gastric Volume
- Reduced Gastrointestinal Microbial Fermentation-Related Intoxication
- Reduced Growth Performance
- Reduced Hunger
- Reduced Immunogenicity After Oral Vaccination
- Reduced Intestinal Aging
- Reduced Isoleucine Level
- Reduced Morphological Damage of the Jejunum
- Reduced Mucosal Permeability
- Reduced Nutrient Content
- Reduced Nutritional Status
- Reduced Occurrence of NEC (Bell's Stage 2 or Higher)
- Reduced Oxalate Nephropathy
- Reduced Precursor Amino Acid Availability
- Reduced Red Blood Cell Folate Concentration
- Reduced Risk of Necrotizing Enterocolitis Surgery
- Reduced Small-Intestinal Enteropathy
- Reduced Stool pH
- Reduced Threonine
- Reduced Time to Full Enteral Feeding
- Reduced Time to Full Feeds
- Reduced Time to Maximum Amino Acid Concentration
- Reduced Urinary Oxalate Excretion
- Reduced Villus Height
- Reduced Vitamin E Level
- Remodeled Intestinal Microbiota
- Resolved Keratomalacia
- Restored Colonic Water Transport
- Successful Gut Colonization
- Survival Through Human Intestine
- Unchanged Growth Parameters
- Unchanged Stool Consistency or Bowel Frequency